These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29522683)

  • 1. A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity.
    Tan J; Li C; Wang Q; Li S; Chen S; Zhang J; Wang PC; Ren L; Liang XJ
    Mol Pharm; 2018 Apr; 15(4):1724-1728. PubMed ID: 29522683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
    Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
    Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer.
    Baz J; Khoury A; Elias MG; Mansour N; Mehanna S; Hammoud O; Gordon CP; Taleb RI; Aldrich-Wright JR; Daher CF
    Chem Biol Interact; 2024 Jan; 388():110834. PubMed ID: 38103879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.
    Hou J; Shang J; Jiao C; Jiang P; Xiao H; Luo L; Liu T
    Macromol Biosci; 2013 Jul; 13(7):954-65. PubMed ID: 23744619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo.
    Song XQ; Ma ZY; Wu YG; Dai ML; Wang DB; Xu JY; Liu Y
    Eur J Med Chem; 2019 Apr; 167():377-387. PubMed ID: 30784875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression.
    Jin S; Guo Y; Song D; Zhu Z; Zhang Z; Sun Y; Yang T; Guo Z; Wang X
    Inorg Chem; 2019 May; 58(9):6507-6516. PubMed ID: 31013065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward supramolecular nanozymes for the photocatalytic activation of Pt(IV) anticancer prodrugs.
    Mazzei LF; Martínez Á; Trevisan L; Rosa-Gastaldo D; Cortajarena AL; Mancin F; Salassa L
    Chem Commun (Camb); 2020 Sep; 56(72):10461-10464. PubMed ID: 32910125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
    Jin S; Hao Y; Zhu Z; Muhammad N; Zhang Z; Wang K; Guo Y; Guo Z; Wang X
    Inorg Chem; 2018 Sep; 57(17):11135-11145. PubMed ID: 30117731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
    Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
    Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.
    Lasorsa A; Stuchlíková O; Brabec V; Natile G; Arnesano F
    Mol Pharm; 2016 Sep; 13(9):3216-23. PubMed ID: 27505350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Anticancer Pt
    Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
    Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H; Xu Z; Li C; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2019 Aug; 58(16):11076-11084. PubMed ID: 31393117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
    Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
    Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
    Montagner D; Tolan D; Andriollo E; Gandin V; Marzano C
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
    Min Y; Li J; Liu F; Yeow EK; Xing B
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.